Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab and Cinacalcet in Primary Hyperparathyroidism
NCT03027557Phase 3Completed
- Start
- Mar 2017
- Primary completion
- Apr 2019
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 3 trial of denosumab, cinacalcet in primary hyperparathyroidism (PHPT). Started Mar 2017; status: completed.
02
Drugs
denosumabcinacalcet
03
Conditions
primary hyperparathyroidism (PHPT)
Beyond the preview
Go deeper on NCT03027557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03027557.